Oral Mucositis - Pipeline Review, H1 2018 by MarketResearchReports.biz
"The Report Oral Mucositis -
Pipeline Review, H1 2018 provides information on pricing, market
analysis, shares, forecast, and company profiles for key industry
participants. - MarketResearchReports.biz"
About
Oral
Mucositis
Market
Global Markets Direct's latest
Pharmaceutical and Healthcare disease pipeline guide Oral Mucositis -
Pipeline Review, H1 2018, provides an overview of the Oral Mucositis
(Gastrointestinal) pipeline landscape.
Get Sample copy of this Report @
https://www.marketresearchreports.biz/sample/sample/1581027
Oral mucositis is the most common type of
mucositis. It is a debilitating complication of cancer surgery,
chemotherapy and radiation. Symptoms include change in color,
hyposalivation, a change in the integrity of the mucosa and the
presence of edema on the lips and/or the tongue. Treatment included
oral decontamination (mouth care) and oral debridement.
Report Highlights
Global Markets Direct's Pharmaceutical
and Healthcare latest pipeline guide Oral Mucositis - Pipeline
Review, H1 2018, provides comprehensive information on the
therapeutics under development for Oral Mucositis (Gastrointestinal),
complete with analysis by stage of development, drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and
latest news and press releases.
The
Oral Mucositis (Gastrointestinal) pipeline guide also reviews of key
players involved in therapeutic development for Oral Mucositis and
features dormant and discontinued projects. The guide covers
therapeutics under Development by Companies /Universities
/Institutes, the molecules developed by Companies in Phase III, Phase
II, Phase I and Preclinical stages are 1, 8, 3 and 5 respectively.
Similarly, the Universities portfolio in Preclinical stages comprises
1 molecules, respectively.
Request for TOC @
https://www.marketresearchreports.biz/reports/1581027/oral-mucositis-pipeline-review-h1-2018-market-research-reports/toc
Oral Mucositis (Gastrointestinal)
pipeline guide helps in identifying and tracking emerging players in
the market and their portfolios, enhances decision making
capabilities and helps to create effective counter strategies to gain
competitive advantage. The guide is built using data and information
sourced from Global Markets Directs proprietary databases,
company/university websites, clinical trial registries, conferences,
SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
Note: Certain content / sections in the
pipeline guide may be removed or altered based on the availability
and relevance of data.
Scope
- The pipeline guide provides a snapshot
of the global therapeutic landscape of Oral Mucositis
(Gastrointestinal).
- The pipeline guide reviews pipeline
therapeutics for Oral Mucositis (Gastrointestinal) by companies and
universities/research institutes based on information derived from
company and industry-specific sources.
- The pipeline guide covers pipeline
products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive
drug profiles for the pipeline products which comprise, product
description, descriptive licensing and collaboration details, R&D
brief, MoA & other developmental activities.
- The pipeline guide reviews key
companies involved in Oral Mucositis (Gastrointestinal) therapeutics
and enlists all their major and minor projects.
- The pipeline guide evaluates Oral
Mucositis (Gastrointestinal) therapeutics based on mechanism of
action (MoA), drug target, route of administration (RoA) and molecule
type.
- The pipeline guide encapsulates all the
dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news
related to pipeline therapeutics for Oral Mucositis
(Gastrointestinal)
View
Report @
https://www.marketresearchreports.biz/reports/1581027/oral-mucositis-pipeline-review-h1-2018-market-research-reports
Reasons to buy
- Procure strategically important
competitor information, analysis, and insights to formulate effective
R&D strategies.
- Recognize emerging players with
potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage.
- Find and recognize significant and
varied types of therapeutics under development for Oral Mucositis
(Gastrointestinal).
- Classify potential new clients or
partners in the target demographic.
- Develop tactical initiatives by
understanding the focus areas of leading companies.
- Plan mergers and acquisitions
meritoriously by identifying key players and its most promising
pipeline therapeutics.
- Formulate corrective measures for
pipeline projects by understanding Oral Mucositis (Gastrointestinal)
pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and
out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and
scope.
- Adjust the therapeutic portfolio by
recognizing discontinued projects and understand from the know-how
what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Oral Mucositis - Overview
Oral Mucositis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by
Universities/Institutes
Oral Mucositis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Oral Mucositis - Companies Involved in
Therapeutics Development
Clevexel Pharma SAS
Colby Pharmaceutical Co
Galera Therapeutics Inc
Humanetics Corp
Innovation Pharmaceuticals Inc
Monopar Therapeutics LLC
Oragenics Inc
Soligenix Inc
Spectrum Pharmaceuticals Inc
Spherium Biomed SL
Oral Mucositis - Drug Profiles
AG-013 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
avasopasem manganese - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BCD-600 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
BIO-300 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
brilacidin tetrahydrochloride - Drug
Profile
Product Description
Mechanism Of Action
R&D Progress
clonidine hydrochloride ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CVXL-0095 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dusquetide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EC-18 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy for Oral Mucositis - Drug
Profile
Product Description
Mechanism Of Action
R&D Progress
Gene Therapy to Activate SOD2 for Oral
Mucositis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GM-0111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HYLP-006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melatonin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
phenylbutyrate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pralatrexate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein to Agonize KGFR for
Chemotherapy Induced Gastrointestinal Mucositis and Oral Mucositis -
Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Protein to Antagonize TGF
beta for Immunology, Dermatology, Gastrointestinal and
Musculoskeletal Disorders - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Oral Mucositis - Dormant Projects
Oral Mucositis - Discontinued Products
Oral Mucositis - Product Development
Milestones
Featured News & Press Releases
Jan 29, 2018: Innovation Pharmaceuticals
Brilacidin Franchise Anchored in Three Clinical Indications Oral
Mucositis, Inflammatory Bowel Disease and Serious Skin Infections;
Expands into Dermatologic Diseases
About us
MarketResearchReports.biz is the most
comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment